HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer
P. Bonaventura, O. Tabone, Y. Estornes, A. Page, V. Mutez, M. Delles, S. Moran, C. Dubois, M. Lacourrege, D. Tawfik, E. Etchegaray, A. Valente, R. Boulos, G. Jimenez Dominguez, N. Chuvin, , S. Depil
This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.
bioRxiv · Jul 13, 2024Immunology